METTL3 depletion contributes to tumour progression and drug resistance via N6 methyladenosine-dependent mechanism in HR+HER2-breast cancer

Ouyang, DJ; Hong, T; Fu, MD; Li, YT; Zeng, LY; Chen, QT; He, HY; Wen, Y; Cheng, Y; Zhou, MR; Zou, QY; Yi, WJ

Zou, QY; Yi, WJ (通讯作者)，Cent South Univ, Xiangya Hosp 2, Dept Gen Surg, 139 Renmin Cent Rd, Changsha 410011, Peoples R China.

BREAST CANCER RESEARCH, 2023; 25 (1):

Abstract

BackgroundChemotherapy is an important strategy for the treatment of hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+H......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索